Sfoglia per AUTORE
GIORDA CB
Collezione ASL Torino 5

  

Items : 37

Diabetic retinopathy screening with confocal fundus camera and artificial intelligence - assisted grading. in European journal of ophthalmology / Eur J Ophthalmol. 2025 Mar;35(2):679-688. doi: 10.1177/11206721241272229. Epub 2024 Aug 7.

2025
ASL Torino 5

Piatti A; Rui C; Gazzina S; Tartaglino B; Romeo F; Manti R; Doglio M; Nada E; Giorda CB;

Feasibility and accuracy of the screening for diabetic retinopathy using a fundus camera and an artificial intelligence pre-evaluation application. in Acta diabetologica / Acta Diabetol. 2024 Jan;61(1):63-68. doi: 10.1007/s00592-023-02172-2. Epub 2023 Sep 7.

2024
ASL Torino 5

Piatti A; Romeo F; Manti R; Doglio M; Tartaglino B; Nada E; Giorda CB;

Hospitalisation for herpes zoster in people with and without diabetes: A 10-year-observational study. in Diabetes research and clinical practice / Diabetes Res Clin Pract. 2024 Apr;210:111603. doi: 10.1016/j.diabres.2024.111603. Epub 2024 Mar 8.

2024
ASL Città di Torino
ASL Torino 3
ASL Torino 5

Costa G; Romeo F; Nada E; Picariello R; Tartaglino B; Giorda CB; Gnavi R;

An update on the incidence of type 1 diabetes during the COVID-19 pandemic years. in Diabetes, obesity & metabolism / Diabetes Obes Metab. 2023 Oct;25(10):3068-3070. doi: 10.1111/dom.15182. Epub 2023 Jul 3.

2023
ASL Città di Torino
ASL Torino 3
ASL Torino 5

Ferro S; Rabbone I; Romeo F; Migliardi A; Favella L; Tartaglino B; Gnavi R; Giorda CB;

Correction to: Increased incidence of type 1 diabetes in 2 years of COVID?19 pandemic. in Acta diabetologica / Acta Diabetol. 2023 May;60(5):719. doi: 10.1007/s00592-023-02072-5.

2023
ASL Città di Torino
ASL Torino 3
ASL Torino 5

Rabbone I; Ferro S; Migliardi A; Favella L; Manti R; Tartaglino B; Gnavi R; Giorda CB;

Hepatocellular carcinoma in a large cohort of type 2 diabetes patients. in Diabetes research and clinical practice / Diabetes Res Clin Pract. 2023 Jun;200:110684. doi: 10.1016/j.diabres.2023.110684. Epub 2023 Apr 24.

2023
ASL Città di Torino
ASL Torino 3
ASL Torino 5

Gnavi R; Monge L; Manti R; Nada E; Costa G; Tartaglino B; Picariello R; Giorda CB;

Increased incidence of type 1 diabetes in 2 years of COVID-19 pandemic. in Acta diabetologica / Acta Diabetol. 2023 Apr;60(4):587-589. doi: 10.1007/s00592-022-01986-w. Epub 2022 Dec 17.

2023
ASL Città di Torino
ASL Torino 3
ASL Torino 5

Rabbone I; Ferro S; Migliardi A; Favella L; Manti R; Tartaglino B; Gnavi R; Giorda CB;

Correction to: Increased incidence of type 1 diabetes in 2 years of COVID?19 pandemic (Acta Diabetologica, (2022), 60, 4, (587-589), 10.1007/s00592-022-01986-w) in Acta Diabetologica

2023
ASL Torino 5

Giorda CB; Gnavi R; Tartaglino B; Manti R; Migliardi A; Favella L; Ferro S; Rabbone I;

Instructive lessons from the analysis of assistance in diabetes during the first phase of COVID-19 pandemic. in Acta diabetologica / Acta Diabetol. 2022 Jun;59(6):861-864. doi: 10.1007/s00592-022-01855-6. Epub 2022 Feb 19.

2022
ASL Città di Torino
ASL Torino 3
ASL Torino 5

Romeo F; Doglio M; Nada E; Tartaglino B; Landriscina T; Picariello R; Giorda CB; Gnavi R;

Hepatic fibrosis of any origin in a large population of type 2 diabetes patients. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2021 Sep 22;31(10):2887-2894. doi: 10.1016/j.numecd.2021.06.020. Epub 202

2021
ASL Città di Torino
ASL Torino 3
ASL Torino 5

Costa G; Romeo F; Linzalata C; Nada E; Picariello R; Tartaglino B; Gnavi R; Giorda CB;

From swab testing to health outcomes within the T2DM population: Impact of diabetes background on COVID19 progression. in Diabetes research and clinical practice / Diabetes Res Clin Pract. 2021 Oct;180:109021. doi: 10.1016/j.diabres.2021.109021. Epub 2021 Aug 23.

2021
ASL Città di Torino
ASL Torino 3
ASL Torino 5

Gnavi R; Romeo F; Costa G; Doglio M; Nada E; Picariello R; Tartaglino B; Giorda CB;

Determinants of good metabolic control without weight gain in type 2 diabetes management: a machine learning analysis. in BMJ open diabetes research & care / BMJ Open Diabetes Res Care. 2020 Sep;8(1):e001362. doi: 10.1136/bmjdrc-2020-001362.

2020
ASL Torino 5

Giorda CB; Pisani F; De Micheli A; Ponzani P; Russo G; Guaita G; Zilich R; Musacchio N;

Prescription of Sulphonylureas among Patients with Type 2 Diabetes Mellitus in Italy: Results from the Retrospective, Observational Multicentre Cross-Sectional SUSCIPE (Sulphonyl_UreaS_Correct_Internal_Prescription_Evaluation) Study. in Diabetes therapy : research, treatment and education of diabetes and related disorders / Diabetes Ther. 2020 Sep;11(9):2105-2119. doi: 10.1007/s13300-020-00871-5. Epub 2020 Jul 30.

2020
ASL Torino 5
AOU San Luigi di Orbassano

Guerzoni C; Cercone S; Bossi AC; De Cosmo S; Orsi E; Giorda CB; Gilio B; Cavalot F;

Incidence of hospitalization and mortality in patients with diabetic foot regardless of amputation: a population study. in Acta diabetologica / Acta Diabetol. 2020 Feb;57(2):221-228. doi: 10.1007/s00592-019-01412-8. Epub 2019 Aug 29.

2020
ASL Torino 3
ASL Torino 5
AOU Città della Salute di Torino

Giorda CB; Boffano GM; Broglio F; Monge L; Gnavi R; Carnà P;

Impact of severe and symptomatic hypoglycemia on quality of life and fear of hypoglycemia in type 1 and type 2 diabetes. Results of the Hypos-1 observational study. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2019 Jul;29(7):736-743. doi: 10.1016/j.numecd.2019.04.009. Epub 2019 May

2019
ASL Torino 3
ASL Torino 4
ASL Torino 5

Lucisano G; Romeo F; Gentile FM; Baccetti F; Chiambretti A; Aglialoro A; Gentile S; Nicolucci A; Ozzello A; Rossi MC; Giorda CB;

Beta cell stress in a 4-year follow-up of patients with type 2 diabetes: A longitudinal analysis of the BetaDecline Study. in Diabetes/metabolism research and reviews / Diabetes Metab Res Rev. 2018 Sep;34(6):e3016. doi: 10.1002/dmrr.3016. Epub 2018 May 21.

2018
ASL Torino 5

Russo GT; Giorda CB; Cercone S; De Cosmo S; Nicolucci A; Cucinotta D;

Ten-year comparative analysis of incidence, prognosis, and associated factors for dialysis and renal transplantation in type 1 and type 2 diabetes versus non-diabetes. in Acta diabetologica / Acta Diabetol. 2018 Jul;55(7):733-740. doi: 10.1007/s00592-018-1142-y. Epub 2018 Apr 20.

2018
ASL Torino 3
ASL Torino 5

Tartaglino B; Costa G; Picariello R; Salomone M; Carnà P; Giorda CB; Gnavi R;

Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2017 Mar;27(3):209-216. doi: 10.1016/j.numecd.2016.10.005. Epub 2016 Nov

2017
ASL Torino 3
ASL Torino 4
ASL Torino 5

Nicolucci A; Lucisano G; Romeo F; Gentile FM; Chiambretti A; Baccetti F; Aglialoro A; Ozzello O; Gentile S; Rossi MC; Giorda CB;

Incidence and correlated factors of beta cell failure in a 4-year follow-up of patients with type 2 diabetes: a longitudinal analysis of the BETADECLINE study. in Acta diabetologica / Acta Diabetol. 2016 Oct;53(5):761-7. doi: 10.1007/s00592-016-0868-7. Epub 2016 May 18.

2016
ASL Torino 5

Giorda CB; Russo GT; Cercone S; De Cosmo S; Nicolucci A; Cucinotta D;

Results of the Adequacy of glycemiC Control in pAtients with type 2 Diabetes mEllitus treated with Metformin monotherapY at the maximal-tolerated dose (ACCADEMY) study. in Endocrine / Endocrine. 2016 Jun;52(3):507-15. doi: 10.1007/s12020-015-0692-9. Epub 2015 Aug 15.

2016
ASL Torino 5

Giorda CB; Cercone S; Nada E;

Gender-Disparities in Adults with Type 1 Diabetes: More Than a Quality of Care Issue. A Cross-Sectional Observational Study from the AMD Annals Initiative. in PloS one / PLoS One. 2016 Oct 3;11(10):e0162960. doi: 10.1371/journal.pone.0162960. eCollection 2016.

2016
ASL Torino 5

Manicardi V; Russo G; Napoli A; Torlone E; Li Volsi P; Giorda CB; Musacchio N; Nicolucci A; Suraci C; Lucisano G; Rossi MC;

Incidence and risk factors for severe and symptomatic hypoglycemia in type 1 diabetes. Results of the HYPOS-1 study. in Acta diabetologica / Acta Diabetol. 2015 Oct;52(5):845-53. doi: 10.1007/s00592-015-0713-4. Epub 2015 Feb 12.

2015
ASL Torino 3
ASL Torino 4
ASL Torino 5

Nicolucci A; Rossi MC; Lucisano G; Gentile FM; Baccetti F; Aglialoro A; Chiambretti A; Gentile S; Ozzello A; Giorda CB;

Incretin-based therapies and acute pancreatitis risk: a systematic review and meta-analysis of observational studies. in Endocrine / Endocrine. 2015 Mar;48(2):461-71. doi: 10.1007/s12020-014-0386-8. Epub 2014 Aug 22.

2015
ASL Torino 5

Giorda CB; Sacerdote C; Nada E; Marafetti L; Baldi I; Gnavi R;

Hospitalisation for heart failure and mortality associated with dipeptidyl peptidase 4 (DPP-4) inhibitor use in an unselected population of subjects with type 2 diabetes: a nested case-control study. in BMJ open / BMJ Open. 2015 Jun 5;5(6):e007959. doi: 10.1136/bmjopen-2015-007959.

2015
ASL Torino 3
ASL Torino 5

Costa G; Alessiato A; Di Noi F; Marafetti L; Tartaglino B; Picariello R; Giorda CB; Gnavi R;

A systematic review of acute pancreatitis as an adverse event of type 2 diabetes drugs: from hard facts to a balanced position. in Diabetes, obesity & metabolism / Diabetes Obes Metab. 2014 Nov;16(11):1041-7. doi: 10.1111/dom.12297. Epub 2014 Apr 29.

2014
ASL Torino 5

Giorda CB; Nada E; Tartaglino B; Marafetti L; Gnavi R;

Improving quality of care in people with Type 2 diabetes through the Associazione Medici Diabetologi-annals initiative: a long-term cost-effectiveness analysis. in Diabetic medicine : a journal of the British Diabetic Association / Diabet Med. 2014 May;31(5):615-23. doi: 10.1111/dme.12366. Epub 2013 Dec 24.

2014
ASL Torino 5

Giorda CB; Nicolucci A; Pellegrini F; Kristiansen CK; Hunt B; Valentine WJ; Vespasiani G;

Comparison of direct costs of type 2 diabetes care: different care models with different outcomes. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2014 Jul;24(7):717-24. doi: 10.1016/j.numecd.2014.01.009. Epub 2014 Jan 2

2014
ASL Torino 3
ASL Torino 5

Costa G; Marafetti L; Tartaglino B; Picariello R; Nada E; Giorda CB; Petrelli A; Gnavi R;

Incretin therapies and risk of hospital admission for acute pancreatitis in an unselected population of European patients with type 2 diabetes: a case-control study. in The lancet. Diabetes & endocrinology / Lancet Diabetes Endocrinol. 2014 Feb;2(2):111-5. doi: 10.1016/S2213-8587(13)70147-5. Epub 2013 Nov 1

2014
ASL Torino 3
ASL Torino 5

Costa G; Marafetti L; Tartaglino B; Nada E; Picariello R; Giorda CB; Gnavi R;

Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment. A systematic review of the literature. in Endocrine / Endocrine. 2014 Aug;46(3):406-19. doi: 10.1007/s12020-014-0179-0. Epub 2014 Feb 8.

2014
ASL Torino 5

Giorda CB; Nada E; Tartaglino B;

Factors associated with beta-cell dysfunction in type 2 diabetes: the BETADECLINE study. in PloS one / PLoS One. 2014 Oct 27;9(10):e109702. doi: 10.1371/journal.pone.0109702. eCollection 2014.

2014
ASL Torino 5

Russo GT; Giorda CB; Cercone S; Nicolucci A; Cucinotta D;

Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes in Nephrology Dialysis Transplantation

2014
ASL Torino 5

De Cosmo S; Rossi MC; Pellegrini F; Lucisano G; Bacci S; Gentile S; Ceriello A; Russo G; Nicolucci A; Giorda C; Viazzi F; Pontremoli R; Antonino C; Danila F; Bruno GC; Illidio M; Antonio N; Fabio P; Chiara RM; Salvatore T; Giacomo V; Graziano G; Memmo R; Pellicciotta E; Paciotti V; Pupillo M; Armentano G; Giovannini C; Armentano V; et alii...

Erratum to: Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment. A systematic review of the literature (Endocrine DOI: 10.1007/s12020-014-0179-0) in Endocrine

2014
ASL Torino 5

Giorda CB; Nada E; Tartaglino B;

Predictors of beta cell dysfunction in type 2 diabetes: The Beta Decline study in Diabetologia

2013
ASL Torino 5

Russo GT; Arcangeli A; Cercone S; Corda A; Cucinotta D; De Cosmo S; Gentile L; Leotta S; Nicolucci A; Pellegrini M; Vespasiani G; Giorda CB;

To what extent is the new position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) 'personalised'? in Diabetologia / Diabetologia. 2012 Oct;55(10):2853-2855. doi: 10.1007/s00125-012-2642-x. Epub 2012 Jul 17.

2012
ASL Torino 5

Ceriello A; Gallo M; Gentile S; Giorda CB; De Micheli A;

Management of newly diagnosed patients with type 2 diabetes: What are the attitudes of physicians? A SUBITO!AMD survey on the early diabetes treatment in Italy in Acta Diabetologica

2012
ASL Torino 5

Suraci C; Mulas F; Rossi MC; Gentile S; Giorda CB;

Could clinical inertia in part explain the unexpected association of insulin therapy with poorer cardiovascular outcomes in observational studies on diabetes? in Diabetes Research and Clinical Practice

2011
ASL Torino 5

Giorda CB;

Recommendations for the implementation of the international standardization of glycated hemoglobin in Italy in Rivista Italiana della Medicina di Laboratorio

2009
ASL Torino 5

Mosca A; Branca MT; Carta M; Genna ML; Giorda CB; Ghidelli R; Ghislandi G; Iafusco D; Lapolla A; Buondonno Lombardi V; Lovagnini Scher CA; Marra M; Medea G; Meschi F; Pizzini A; Rossi F; Scalpone R; Tofini G; Trovati M; Zaninotto M;